Original Source(s)
Related Content
FDA approves dostarlimab for advanced rectal cancer
The accelerated approval adds an immunotherapy option for patients with MSI-H/dMMR stage II/III disease.
by Mouj Hijazi
October 19, 2026
-
3 min
FDA raises TMB threshold for pembrolizumab
Traditional approval narrows eligibility for previously treated solid tumors after efficacy was not confirmed at lower biomarker levels.
by Mouj Hijazi
October 23, 2026
-
3 min
Why Better Care Needs Better Connections
Improving the flow of diagnostic information across care teams can save money, reduce delays, and support better patient outcomes
October 29, 2026
-
5 min
